Dubinsky, Samuel <br/><br/>
Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone.  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  Sep 2019 
 - 3209-3217 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1433-7339 
<br/><br/><label>Standard No.: </label>10.1007/s00520-019-04816-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstenes--adverse effects<br/>Anticoagulants--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Disease Progression<br/>Drug Interactions<br/>Humans<br/>Male<br/>Prednisone--therapeutic use<br/>Prostatic Neoplasms, Castration-Resistant--blood<br/>Quality of Life<br/>Retrospective Studies<br/>Thrombosis--drug therapy<br/>Treatment Outcome